BIOMAT Database Logo BIOMAT Database Logo

Evaluation of a competitive binding assay for cortisol using horse transcortin. 1978

F Stahl, and W Hubl, and D Schnorr, and G Dörner

A non-chromatographic competitive binding assay (CBA) using horse transcortin has been employed in the routine measurement of cortisol in plasma, urine and amniotic fluids. Comparing the values with those of a radioimmunoassay (RIA) or a fluorimetric method (FM) an excellent correlation between the three methods both in plasma and urine has been calculated in normal subjects and in patients with various endocrine disorders. In amniotic fluids, however, there were discrepancies between CBA and RIA. Whereas CBA showed no differences, RIA gave significantly higher values in amniotic fluids of female than of male fetuses. Elevated free plasma cortisol levels observed in patients with prostatic cancer after diethyl stilboestrol diphosphate therapy did not correlate with unconjugated urinary cortisol concentration as measured with CBA and FM. In newborns, a relatively high plasma level found 12 hours after birth was followed by a nadir on the 2nd and 3rd day of life and by an increase until levels of adults on the 5th day of life were reached.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D004054 Diethylstilbestrol A synthetic nonsteroidal estrogen used in the treatment of menopausal and postmenopausal disorders. It was also used formerly as a growth promoter in animals. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), diethylstilbestrol has been listed as a known carcinogen. (Merck, 11th ed) Stilbestrol,Agostilben,Apstil,Diethylstilbestrol, (Z)-Isomer,Diethylstilbestrol, Disodium Salt,Distilbène,Stilbene Estrogen,Tampovagan,Estrogen, Stilbene
D004700 Endocrine System Diseases Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. Endocrine Diseases,Diseases of Endocrine System,Disease, Endocrine,Disease, Endocrine System,Diseases, Endocrine,Diseases, Endocrine System,Endocrine Disease,Endocrine System Disease,System Disease, Endocrine,System Diseases, Endocrine
D005260 Female Females
D005312 Fetal Blood Blood of the fetus. Exchange of nutrients and waste between the fetal and maternal blood occurs via the PLACENTA. The cord blood is blood contained in the umbilical vessels (UMBILICAL CORD) at the time of delivery. Cord Blood,Umbilical Cord Blood,Blood, Cord,Blood, Fetal,Blood, Umbilical Cord,Bloods, Cord,Bloods, Fetal,Bloods, Umbilical Cord,Cord Blood, Umbilical,Cord Bloods,Cord Bloods, Umbilical,Fetal Bloods,Umbilical Cord Bloods

Related Publications

F Stahl, and W Hubl, and D Schnorr, and G Dörner
Radioligand binding assay of cortisol using horse transcortin.
September 1979, The Indian journal of medical research,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
[Determination of plasma cortisol by competitive binding with transcortin].
January 1970, Annales de biologie clinique,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
Evaluation of a simple cortisol assay by competitive protein binding technique.
December 1976, Clinical biochemistry,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
A simple competitive protein binding assay for plasma cortisol.
September 1974, Clinica chimica acta; international journal of clinical chemistry,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
Cortisol binding affinity of plasma transcortin (CBA) as studied by competitive adsorption.
September 1968, The Journal of clinical endocrinology and metabolism,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
The simultaneous estimation of plasma cortisol and transcortin binding characteristics by a competitive protein binding technique.
December 1969, Steroids,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
Assessment of a simple competitive protein-binding technique for plasma cortisol assay.
March 1975, Annals of clinical biochemistry,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
Rapid, specific assay for plasma cortisol by competitive protein binding.
September 1975, Clinical chemistry,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
Critical evaluation of competitive protein-binding radioassay for cortisol.
January 1969, Annales d'endocrinologie,
F Stahl, and W Hubl, and D Schnorr, and G Dörner
FACTORS AFFECTING THE BINDING OF CORTISOL BY TRANSCORTIN.
September 1963, Acta endocrinologica,
Copied contents to your clipboard!